Involvement of cyclin-dependent kinase 5 in 2,5-hexanedione-induced neuropathy

Toxicology

Volumn 248, Issue 1, 2008, Pages 1-7

  Wang, Qing Shan ^a   Zhang, Cui Li ^a   Hou, Li Yan ^a   Zhao, Xiu Lan ^a   Yang, Xi Wei ^a   Xie, Ke Qin ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

2,5 Hexanedione; Cyclin dependent kinase 5 (CDK5); Neurofilaments; Phosphorylation

Indexed keywords

ACETONYLACETONE; CYCLIN DEPENDENT KINASE 5; HEXANE; PROTEIN P25; PROTEIN P35;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOSOLIC FRACTION; ENZYME ACTIVITY; GAIT DISORDER; IMMUNOBLOTTING; MALE; NERVE DEGENERATION; NEUROPATHY; NEUROTOXICITY; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; SCIATIC NERVE; SCORING SYSTEM; SPINAL CORD; WESTERN BLOTTING;

ANIMALS; CEREBRAL CORTEX; CYCLIN-DEPENDENT KINASE 5; GAIT; HEXANONES; MALE; NEUROTOXINS; PHOSPHOTRANSFERASES; RATS; RATS, WISTAR; SCIATIC NERVE; SPINAL CORD;

RATTUS;

EID: 42749092817     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2008.02.019     Document Type: Article

References (59)

1. Abou-Donia M.B., Lapadula D.M., and Suwita E. Cytoskeletal proteins as targets for organophosphorus compound and aliphatic hexacarbon-induced neurotoxicity. Toxicology 49 (1988) 469-477
2. Abou-Donia M.B., Viana M.E., Gupta R.P., and Anderson J.K. Enhanced calmodulin binding concurrent with increased kinase-dependent phosphorylation of cytoskeletal proteins following a single subcutaneous injection of diisopropyl phosphorofluoridate in hens. Neurochem. Int. 22 (1993) 165-173
3. Ackerley S., Thornhill P., Grierson A.J., Brownlees J., Anderton B.H., Leigh P.N., Shaw C.E., and Miller C.C. Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments. J. Cell Biol. 161 (2003) 489-495
4. Ahlijanian M.K., Barrezueta N.X., Williams R.D., Jakowski A., Kowsz K.P., McCarthy S., Coskran T., Carlo A., Seymour P.A., Burkhardt J.E., Nelson R.B., and McNeish J.D. Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 2910-2915
5. Banik N.L., Matzelle D.C., Gantt-Wilford G., Osborne A., and Hogan E.L. Increased calpain content and progressive degradation of neurofilament protein in spinal cord injury. Brain Res. 752 (1997) 301-306
6. Bu B., Li J., Davies P., and Vincent I. Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model. J. Neurosci. 22 (2002) 6515-6525
7. Carden M.J., Lee V.M., and Schlaepfer W.W. 2,5-Hexanedione neuropathy is associated with the covalent crosslinking of neurofilament proteins. Neurochem. Pathol. 5 (1986) 25-35
8. Chiu F.C., Opanashuk L.A., He D.K., Lehning E.J., and LoPachin R.M. Gamma-diketone peripheral neuropathy. II. Neurofilament subunit content. Toxicol. Appl. Pharmacol. 165 (2000) 141-147
9. Cruz J.C., Tseng H.C., Goldman J.A., Shih H., and Tsai L.H. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40 (2003) 471-483
10. Dhavan R., and Tsai L.H. A decade of CDK5. Nat. Rev. Mol. Cell Biol. 2 (2001) 749-759
11. Fliegner K.H., and Liem R.K. Cellular and molecular biology of neuronal intermediate filaments. Int. Rev. Cytol. 131 (1991) 109-167
12. Gilbert S.G., and Maurissen J.P. Assessment of the effects of acrylamide, methylmercury, and 2,5-hexanedione on motor functions in mice. J. Toxicol. Environ. Health 10 (1982) 31-41
13. Gong X., Tang X., Wiedmann M., Wang X., Peng J., Zheng D., Blair L.A., Marshall J., and Mao Z. Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron 38 (2003) 33-46
14. Graham D.G., Amarnath V., Valentine W.M., Pyle S.J., and Anthony D.C. Pathogenetic studies of hexane and carbon disulfide neurotoxicity. Crit. Rev. Toxicol. 25 (1995) 91-112
15. Gupta R.P., and Abou-Donia M.B. Alterations in the neutral proteinase activities of central and peripheral nervous systems of acrylamide-, carbon disulfide-, or 2,5-hexanedione-treated rats. Mol. Chem. Neuropathol. 29 (1996) 53-66
16. Harper J.W., and Adams P.D. Cyclin-dependent kinases. Chem. Rev. 101 (2001) 2511-2526
17. Jensen K.F., Lapadula D.M., Anderson J.K., Haykal-Coates N., and Abou-Donia M.B. Anomalous phosphorylated neurofilament aggregations in central and peripheral axons of hens treated with tri-ortho-cresyl phosphate (TOCP). J. Neurosci. Res. 33 (1992) 455-460
18. Jung C., and Shea T.B. Regulation of neurofilament axonal transport by phosphorylation in optic axons in situ. Cell Motil. Cytoskeleton 42 (1999) 230-240
19. Jung C., Yabe J.T., and Shea T.B. C-terminal phosphorylation of the high molecular weight neurofilament subunit correlates with decreased neurofilament axonal transport velocity. Brain Res. 856 (2000) 12-19
20. Lapadula D.M., Suwita E., and Abou-Donia M.B. Evidence for multiple mechanisms responsible for 2,5-hexanedione-induced neuropathy. Brain Res. 458 (1988) 123-131
21. Lee K.Y., Clark A.W., Rosales J.L., Chapman K., Fung T., and Johnston R.N. Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain. Neurosci. Res. 34 (1999) 21-29
22. Lee M.S., Kwon Y.T., Li M., Peng J., Friedlander R.M., and Tsai L.H. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405 (2000) 360-364
23. Lehning E.J., Dyer K.S., Jortner B.S., and LoPachin R.M. Axonal atrophy is a specific component of 2,5-hexanedione peripheral neuropathy. Toxicol. Appl. Pharmacol. 135 (1995) 58-66
24. Lehning E.J., Jortner B.S., Fox J.H., Arezzo J.C., Kitano T., and LoPachin R.M. Gamma-diketone peripheral neuropathy. I. Quality morphometric analyses of axonal atrophy and swelling. Toxicol. Appl. Pharmacol. 165 (2000) 127-140
25. LoPachin R.M., He D., and Reid M.L. 2,5-Hexanedione-induced changes in the neurofilament subunit pools of rat peripheral nerve. Neurotoxicology 26 (2005) 229-240
26. LoPachin R.M., Jortner B.S., Reid M.L., and Das S. Gamma-diketone central neuropathy: quantitative morphometric analysis of axons in rat spinal cord white matter regions and nerve roots. Toxicol. Appl. Pharmacol. 193 (2003) 29-46
27. 2+/calmodulin-dependent protein kinase II in rat cerebral cortex. Alcohol 23 (2001) 183-188
28. Matsubara M., Kusubata M., Ishiguro K., Uchida T., Titani K., and Taniguchi H. Site-specific phosphorylation of synapsin I by mitogen-activated protein kinase and Cdk5 and its effects on physiological functions. J. Biol. Chem. 271 (1996) 21108-21113
29. Monaco S., Jacob J., Jenich H., Patton A., Autilio-Gambetti L., and Gambetti P. Axonal transport of neurofilament is accelerated in peripheral nerve during 2,5-hexanedione intoxication. Brain Res. 491 (1989) 328-334
30. Nguyen M.D., Larivière R.C., and Julien J.P. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30 (2001) 135-147
31. Nguyen M.D., Mushynski W.E., and Julien J.P. Cycling at the interface between neurodevelopment and neurodegeneration. Cell Death Differ. 9 (2002) 1294-1306
32. Nixon R.A. Dynamic behavior and organization of cytoskeletal proteins in neurons: reconciling old and new findings. Bioessays 20 (1998) 798-807
33. Nixon R.A., Paskevich P.A., Sihag R.K., and Thayer C.Y. Phosphorylation on carboxyl terminus domains of neurofilament proteins in retinal ganglion cell neurons in vivo: influences on regional neurofilament accumulation, interneurofilament spacing, and axon caliber. J. Cell Biol. 126 (1994) 1031-1046
34. Nixon R.A. The regulation of neurofilament protein dynamics by phosphorylation: clues to neurofibrillary pathobiology. Brain Pathol. 3 (1993) 29-38
35. Opanashuk L.A., He D.K., Lehning E.J., and Lopachin R.M. Gamma-diketone peripheral neuropathy III. Neurofilament gene expression. Neurotoxicology 22 (2001) 215-220
36. Pant H.C., and Veeranna. Neurofilament phosphorylation. Biochem. Cell Biol. 73 (1995) 575-592
37. Patrick G.N., Zukerberg L., Nikolic M., de la Monte S., Dikkes P., and Tsai L.H. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402 (1999) 615-622
38. Paudel H.K., Lew J., Ali Z., and Wang J.H. Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments. J. Biol. Chem. 268 (1993) 23512-23518
39. Sánchez I., Hassinger L., Sihag R.K., Cleveland D.W., Mohan P., and Nixon R.A. Local control of neurofilament accumulation during radial growth of myelinating axons in vivo. Selective role of site-specific phosphorylation. J. Cell Biol. 151 (2000) 1013-1024
40. Shea T.B., Yabe J.T., Ortiz D., Pimenta A., Loomis P., Goldman R.D., Amin N., and Pant H.C. Cdk5 regulates axonal transport and phosphorylation of neurofilaments in cultured neurons. J. Cell Sci. 117 (2004) 933-941
41. Shuang R., Zhang L., Fletcher A., Groblewski G.E., Pevsner J., and Stuenkel E.L. Regulation of Munc-18/syntaxin 1A interaction by cyclin-dependent kinase 5 in nerve endings. J. Biol. Chem. 273 (1998) 4957-4966
42. Smith D.S., and Tsai L.H. Cdk5 behind the wheel: a role in trafficking and transport?. Trends Cell Biol. 12 (2002) 28-36
43. Song F., Zhang C., Yu S., Zhao X., Yu L., and Xie K. Time-dependent alteration of cytoskeletal proteins in cerebral cortex of rat during 2,5-hexanedione-induced neuropathy. Neurochem. Res. 32 (2007) 1407-1414
44. Spencer P.S., and Schaumburg H.H. Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration. J. Neuropathol. Exp. Neurol. 36 (1977) 276-299
45. Sun D., Leung C.L., and Liem R.K. Phosphorylation of the high molecular weight neurofilament protein (NF-H) by Cdk5 and p35. J. Biol. Chem. 271 (1996) 14245-14251
46. Suwita E., Lapadula D.M., and Abou-Donia M.B. Calcium and calmodulin-enhanced in vitro phosphorylation of hen brain cold-stable microtubules and spinal cord neurofilament triplet proteins after a single oral dose of tri-o-cresyl phosphate. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 6174-6178
47. Tarricone C., Dhavan R., Peng J., Areces L.B., Tsai L.H., and Musacchio A. Structure and regulation of the CDK5-p25(nck5a) complex. Mol. Cell 8 (2001) 657-669
48. 2+ signalling in K562 human erythroleukaemia cells: effect of dimethyl sulphoxide and role of G-proteins in thrombin- and thromboxane A2-activated pathways. Biochem. J. 312 (1995) 151-158
49. Trojanowski J.Q., Schmidt M.L., Shin R.W., Bramblett G.T., Rao D., and Lee V.M. Altered tau and neurofilament proteins in neuro-degenerative diseases: diagnostic implications for Alzheimer's disease and Lewy body dementias. Brain Pathol. 3 (1993) 45-54
50. Tsai L.H., Delalle I., Caviness Jr. V.S., Chae T., and Harlow E. p35 Is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371 (1994) 419-423
51. Tsai L.H., Lee M.S., and Cruz J. Cdk5, a therapeutic target for Alzheimer's disease?. Biochim. Biophys. Acta 1697 (2004) 137-142
52. Wang Q.S., Hou L.Y., Zhang C.L., Song F.Y., and Xie K.Q. Changes of cytoskeletal proteins in nerve tissues and serum of rats treated with 2,5-hexanedione. Toxicology 244 (2008) 166-178
53. Wang Q.S., Song F.Y., Zhao X.L., Hou L.Y., and Xie K.Q. Expression changes of apoptotic-related proteins in nerve tissues of rats treated with allyl chloride. Toxicology 231 (2007) 58-67
54. Wang Q.S., Zhang C.L., Zhao X.L., Yu S.F., and Xie K.Q. Malondialdehyde and catalase as the serum biomarkers of allyl chloride-induced toxic neuropathy. Toxicology 227 (2006) 36-44
55. 2+/calmodulin-dependent kinase phosphorylation of cytoskeletal proteins in the rat central nervous system. Brain Res. 628 (1993) 293-300
56. Yabe J.T., Chylinski T., Wang F.S., Pimenta A., Kattar S.D., Linsley M.D., Chan W.K., and Shea T.B. Neurofilaments consist of distinct populations that can be distinguished by C-terminal phosphorylation, bundling, and axonal transport rate in growing axonal neurites. J. Neurosci. 21 (2001) 2195-2205
57. Zhai Q., Wang J., Kim A., Liu Q., Watts R., Hoopfer E., Mitchison T., Luo L., and He Z. Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration. Neuron 39 (2003) 217-225
58. Zhang T., Zhao X., Zhu Z., Yu L., Han X., Zhang C., and Xie K. 2,5-Hexanedione induced decrease in cytoskeletal proteins of rat sciatic-tibial nerve. Neurochem. Res. 30 (2005) 177-183
59. Zheng M., Leung C.L., and Liem R.K. Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system. J. Neurobiol. 35 (1998) 141-159